Communication
Why the misinformation and disinformation bill is binned for good
The Australian Government’s misinformation bill was formally abandoned over the weekend after it failed to secure support in the Senate. […]
MoreCommunication
Australians’ trust in mainstream health media is in crisis
Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]
MoreCommunication
Breaking the chains: Unveiling Australia’s media monopoly crisis
A Senate committee is considering a proposal for a parliamentary commission of inquiry into the Murdoch media empire and media […]
MoreCommunication
Consumers call out wishy-washy sustainability initiatives
Millions of social media conversations uncovered that Aussies are becoming ‘hyper-aware’ of greenwashing. Greenwashing is when a company claims to […]
MoreCommunication
Why over 50% of women in comms and PR roles face roadblocks to career advancement
More than one in two women in communications and public relations roles rate the industry’s commitment to gender equality as […]
MoreCommunication
Calls to ‘plug the gap’ in PR and comms industry
The public relations and communications industry is struggling to meet an increase in demand as vacancies remain unfilled due to low numbers […]
MoreCommunication
CSL the only healthcare company to win Asia Pacific award
CSL, a global biotech leader, is the only healthcare company that has been recognised for excellence in communications within the […]
MoreCommunication
Trends shaping corporate communications landscape in 2022 – Deep dive with Baxter and Johnson & Johnson leaders
Navigating how best to communicate with internal and external stakeholders has been an ongoing challenge for many communications executives since […]
MoreCommunication
Shifts in corporate communications landscape and key trends for 2022 – Deep dive with Sanofi, AbbVie and AstraZeneca leaders
In today’s post-COVID recovery world, the role of corporate communications has evolved to become more visible; a trusted business leader […]
MoreCommunication
Janssen leader awarded Best PR Professional in Asia-Pacific region
The PRWeek Awards Asia celebrates the most outstanding, inspired and successful campaigns, individuals and companies in the Asia-Pacific’s communications industry. […]
MoreRecent Posts in Pharma, MedTech & Biotech
Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
April 17, 2025
in News & Trends - MedTech & Diagnostics
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
April 17, 2025
in News & Trends - Pharmaceuticals
The high cost of record low research funding
April 17, 2025
in Medical and Science
UCB secures dermatology indication with first dual IL-17A/F inhibitor
April 17, 2025
in News & Trends - Pharmaceuticals
New Medicines Australia policy leader critical to HTA reforms
April 15, 2025
in Leadership & Management
How Australia’s employee engagement measures up
April 15, 2025
in Human Resources
PBAC issues criticism of pharma industry’s reimbursement submissions
April 15, 2025
in News & Trends - Pharmaceuticals
Surgeons warn patient care at risk as government drags its feet
April 15, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - MedTech & Diagnostics
Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science
The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals
UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More